| dc.contributor.author |
Alkan, A |
|
| dc.contributor.author |
Kutlu, R |
|
| dc.contributor.author |
Yakinci, C |
|
| dc.contributor.author |
Sigirci, A |
|
| dc.contributor.author |
Aslan, M |
|
| dc.contributor.author |
Sarac, K |
|
| dc.date.accessioned |
2022-03-16T11:18:54Z |
|
| dc.date.available |
2022-03-16T11:18:54Z |
|
| dc.date.issued |
2003 |
|
| dc.identifier.uri |
http://hdl.handle.net/11616/56019 |
|
| dc.description.abstract |
Rhizomelic chondrodysplasia punctata is a member of genetic peroxisomal disorders. Delayed myelination, which is probably related to the inadequacy of plasmalogens biosynthesis, is an important feature of this disorder. Direct assessment of neuropathologic aspects of RCDP syndrome such as neuronal degeneration and delayed myelination is possible with MR spectroscopy. |
|
| dc.description.abstract |
In this report, MR spectroscopy findings (decreased Cho/Cr and increased Ins-Gly/Cr ratios and increased levels of mobile lipids) of a rhizomelic chondrodysplasia punctata case supporting delayed myelination are presented. This is the second report of MR spectroscopy examination of the specific brain metabolic changes associated with rhizomelic chondrodysplasia punctata. (C) 2003 Elsevier Science Inc. All rights reserved. |
|
| dc.source |
MAGNETIC RESONANCE IMAGING |
|
| dc.title |
Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR |
|
| dc.title |
spectroscopy findings |
|